APPLICATIONS PUBLISHED 31 JULY 2002
Published: 1-Feb-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Use of a bis-perxovanadium compound for the treatment of immunosuppressed patients
Virocell 1225891*
Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents
Paraquests 1225892*
A pharmaceutical compsn containing lycopene for stabilising atherosclerotic plaques
Aventis 1225893*
FAB I inhibitors
SmithKline Beecham 1225894*
Isoxazole derivatives to be used as phosphodiesterase VII inhibitors
Merck Patents 1225896*
Compsn and treatment of constipation and irritable bowel syndrome
Rodeva 1225897*
Pharmaceutical compsns containing a fluoroquinolone antibiotic drug and xanthan gum
Alcon Universal 1225898*
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
Biochem Pharma 1225899*
Use of dipyrimidamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
Boehringer Ingelheim Pharma 1225900*
Uses and compsns for treating platelet-related disorders using anagrelide
Emory University 1225901*
Ciclesonide contained pharmaceutical compsn for application to mucosa
Byk Gulden Lomberg Chemische Fabrik 1225902*
Aminoalkylenephosphonates for treatment of bone disorders
The Dow Chemical Company 1225903*
Combinations of lamivudine and entecavir for treatment of hepatitis B virus infection
Glaxo Group 1225904*
The use of a positively charged carbohydrate polymer for the prevention of infection
Medicarb 1225905*
Mechanically elongated neuronal cells and methods for producing and using these cells
The Trustees of the University of Pennsylvania 1225906*
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compsns
Epimmune 1225907*
Therapeutic applications of flint polypeptides
Eli Lilly 1225908*
Fibroblast growth factor-5 (FGF-5) is a tumour associated T-cell antigen
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1225909*
Modulation of enos activity and therapeutic uses thereof
Genentech 1225910*
Methods of treating or prevention cell, tissue and organ damage using human myeloid progenitor inhibitory factor-1 (MPIF-1)
Human Genome Sciences 1225911*
A method of prophylaxis and treatment
The Walter and Eliza Hall Institute of Medical Research 1225912*
Use of nitric oxide for the treatment of airway constriction
AGA AB 1225913*
A method to improve protective immunity induced by polynucleotide vaccines
US Government as represented by the Secretary of the Navy 1225914*
Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
Ophidian Pharmaceuticals 1225915*
Compsns and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing
University Technology Corp 1225916*
Manufacture of polyglutamate-therapeutic agent conjugates
Cell Therapeutics 1225917*
Conjugates useful in the treatment of prostate cancer
Merck 1225918*
Treatment of cancer
Unisearch 1225919*
DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
Powderject Vaccines 1225920*
Techniques and compsns for treating cardiovascular disease by in vivo gene delivery
The Regents of the University of California 1225921*
Selective toxin expression in angiogenic endothelial cells
MBT Munich Biotechnology 1225922*
Method of inactivating pathogens
American National Falls Cross 1225923*
Protection of labile proteins during iodine disinfection
Shanbrom Technologies 1225924*
